Top-News
Biotechnologie USA

MultiCell Technologies News

Aktie
WKN:  A0ET6A ISIN:  US62544S2005 US-Symbol:  MCET
-    $
+0,00 $
0,00%
22.05.24 16:16:32
Handeln Depot/Watchlist
Aktienanzahl *
5,00 Mrd.
Marktkapitalisierung *
4,61 Tsd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 30.07.2021

MultiCell Technologies News

25.08.14 - PR Newswire
MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer
MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer PR Newswire
20.03.14 - PR Newswire
MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer
MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer PR Newswire
15.01.14 - PR Newswire
MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics
MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics PR Newswire
13.11.13 - PR Newswire
MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment
MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment PR Newswire
02.10.13 - PR Newswire
MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer
MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer PR Newswire
06.08.13 - PR Newswire
MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer PR Newswire
16.05.13 - PR Newswire
MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer PR Newswire
26.12.12 - PR Newswire
MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting
MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting PR Newswire
22.10.12 - PR Newswire
Grant G. Miller Joins Board of MultiCell Technologies
Grant G. Miller Joins Board of MultiCell Technologies PR Newswire
27.09.12 - PR Newswire
MultiCell Technologies To Announce Positive Preclinical Results at 2012 ASCB Meeting
MultiCell Technologies To Announce Positive Preclinical Results at 2012 ASCB Meeting PR Newswire
06.09.12 - PR Newswire
Scott Lukeman, Ph.D., Joins Board of MultiCell Technologies
Scott Lukeman, Ph.D., Joins Board of MultiCell Technologies PR Newswire
14.08.12 - PR Newswire
MultiCell Announces Results of Shareholders' Meeting
MultiCell Announces Results of Shareholders' Meeting PR Newswire
10.08.12 - PR Newswire
MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models
MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models PR Newswire

Newssuche

Videos

newspaper
29.05.24
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »